|
|
|
Volumn 78, Issue SUPPL. 3, 1998, Pages 1-7
|
|
Scientific symposium on New Antimetabolites in Cancer Chemotherapy and their Clinical Impact, Southampton, UK, April 1997: New antimetabolites in cancer chemotherapy and their clinical impact
|
|
Author keywords
Antimetabolite; Cancer chemotherapy; Gemcitabine; Multi targeted antifolate; Raltitrexed
|
|
Indexed keywords
10 PROPARGYL 5,8 DIDEAZAFOLIC ACID;
AG 2009;
AG 2032;
AMINOPTERIN;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
CAPECITABINE;
CYTARABINE;
DIHYDROFOLATE REDUCTASE INHIBITOR;
EDATREXATE;
FLUOROURACIL;
FOLIC ACID;
FOLIC ACID ANTAGONIST;
FOLINIC ACID;
GEMCITABINE;
LOMETREXOL;
MERCAPTOPURINE;
METHOTREXATE;
N [5 [2 (2 AMINO 1,4,5,6,7,8 HEXAHYDRO 4 OXOPYRIDO[2,3 D]PYRIMIDIN 6 YL)ETHYL] 2 THENOYL]GLUTAMIC ACID;
N [[5 [2 (2 AMINO 4,6,7,8 TETRAHYDRO 4 OXO 1H PYRIMIDO[5,4 B][1,4]THIAZIN 6 YL)ETHYL] 2 THIENYL]CARBONYL]GLUTAMIC ACID;
NOLATREXED;
NUCLEOSIDE ANALOG;
PEMETREXED;
PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE;
PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE;
PIRITREXIM;
PLEVITREXED;
RALTITREXED;
THYMIDYLATE SYNTHASE INHIBITOR;
TRIMETREXATE;
UNCLASSIFIED DRUG;
BLADDER CANCER;
BONE MARROW SUPPRESSION;
BONE PAIN;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG RESISTANCE;
DRUG STRUCTURE;
DRUG TARGETING;
FEVER;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKEMIA;
LUNG NON SMALL CELL CANCER;
MUCOSA INFLAMMATION;
MYALGIA;
NAUSEA;
NEPHROTOXICITY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
OVARY CANCER;
PANCREAS CANCER;
PANCYTOPENIA;
PRIORITY JOURNAL;
THORAX PAIN;
THROMBOCYTOPENIA;
|
|
EID: 0031825771
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (107)
|
|
References (68)
|
